The SEQUENCE Trial: Evaluating Diagnostic Yield of Robotic-assisted Bronchoscopy When Staging EBUS is Performed First or Second in the Same Procedure
Not Applicable
Recruiting
- Conditions
- Registration Number
- NCT06676956
- Lead Sponsor
- Northwestern University
- Brief Summary
Robotic-assisted bronchoscopy (RaB) has afforded proceduralists the ability to accurately reach the periphery of the lung for biopsy of pulmonary nodules1. This has paved the way for patients to undergo both biopsy of a peripheral nodule and a staging linear endobronchial ultrasound (EBUS) in the same anesthesia event, promoting quicker throughput from disco...
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 320
Inclusion Criteria
- Peripheral Pulmonary Nodule undergoing a robotic-assisted bronchoscopy
Read More
Exclusion Criteria
- lymph nodes that are enlarged or PET avid on CT prior to procedure
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Diagnostic yield from the procedure This will be assessed 30 days after the procedure in a study visit that our teams conduct, it will not include the patient This will be an outcome measure that is positive or negative based on whether a diagnosis was achieved during the procedure
- Secondary Outcome Measures
Name Time Method Atelectasis This will be assessed day of procedure and recorded Using the IPOG atelectasis score (three outcomes) we will track the impact atelectasis has on the biopsy and diagnostic yield
Trial Locations
- Locations (1)
Northwestern University
🇺🇸Chicago, Illinois, United States